Background: Infection of human bronchial epithelial cells (hBECs) with respiratory syncytial virus (RSV) has been shown to induce a Th lymphocyte subset drift, e.g. enhanced differentiation of Th2 and Th17 subsets, which is a classic characteristic of asthma. However, the molecules responsible for the drift in Th subsets remain unknown. This study aims to determine the expression of leptin in RSV-infected hBECs, and its role in Th2 and Th17 cell differentiation and extracellular regulated kinase (ERK) 1/2 phosphorylation. Methods: Cultured hBECs were infected with RSV. mRNA expression of the LEP gene in cells was measured by real-time PCR while LEP protein secretion in culture medium was measured by ELISA. Th differentiation was investigated in cultured human peripheral blood mononuclear cells following stimulation with recombinant human leptin. Th2 and Th17 subsets were examined by flow cytometry. Phosphorylation of the ERK1/2 protein in lymphocytes was detected by Western blot and immunofluorescence. Results: LEP mRNA expression was significantly upregulated in RSV-infected hBECs while the leptin protein level in the supernatants of RSV-infected hBECs was significantly increased. Stimulation of lymphocytes with leptin increased the differentiation of the Th17 subset and ERK1/2 phosphorylation, but suppressed Th2 subset differentiation. Conclusion: Leptin was oversecreted by RSV-infected hBECs, which promoted Th17 subset differentiation but suppressed Th2 subset differentiation possibly via regulating ERK1/2 phosphorylation.

Keywords:
Human bronchial epithelial cells, Leptin, Respiratory syncytial virus, Th2, Th17
1.
Han J, Takeda K, Gelfand EW: The role of RSV infection in asthma initiation and progression: findings in a mouse model. Pulm Med 2011;2011:748038.
2.
Knudson CJ, Varga SM: The relationship between respiratory syncytial virus and asthma. Vet Pathol 2015;52:97-106.
3.
Zhao Y, Yang J, Gao YD: Altered expressions of helper T cell (Th)1, Th2, and Th17 cytokines in CD8(+) and γδ T cells in patients with allergic asthma. J Asthma 2011;48:429-436.
4.
Wong CK, Ho CY, Ko FW, Chan CH, Ho AS, Hui DS, Lam CW: Proinflammatory cytokines (IL-17, IL-6, IL-18 and IL-12) and Th cytokines (IFN-gamma, IL-4, IL-10 and IL-13) in patients with allergic asthma. Clin Exp Immunol 2001;125:177-183.
5.
Zhao Y, Yang J, Gao YD, Guo W: Th17 immunity in patients with allergic asthma. Int Arch Allergy Immunol 2010;151:297-307.
6.
Hacking D, Hull J: Respiratory syncytial virus - viral biology and the host response. J Infect 2002;45:18-24.
7.
Qin L, Hu CP, Feng JT, Xia Q: Activation of lymphocytes induced by bronchial epithelial cells with prolonged RSV infection. PLoS One 2011;6:e27113.
8.
Zhang Y, Proenca R, Maffei M, Barone M, Leopold L, Friedman JM: Positional cloning of the mouse obese gene and its human homologue. Nature 1994;372:425-432.
9.
Friedman JM, Halaas JL: Leptin and the regulation of body weight in mammals. Nature 1998;395:763-770.
10.
Vernooy JH, Drummen NE, van Suylen RJ, Cloots RH, Moller GM, Bracke KR, Zuyderduyn S, Dentener MA, Brusselle GG, Hiemstra PS: Enhanced pulmonary leptin expression in patients with severe COPD and asymptomatic smokers. Thorax 2009;64:26-32.
11.
Bruno A, Pace E, Chanez P, Gras D, Vachier I, Chiappara G, La Guardia M, Gerbino S, Profita M, Gjomarkaj M: Leptin and leptin receptor expression in asthma. J Allergy Clin Immunol 2009;124:230-237.
12.
Margalet VS, Romero CM: Human leptin signaling in human peripheral blood mononuclear cells: activation of the JAK-STAT pathway. Cell Immunol 2001;211:30-36.
13.
Romero CM, Margalet VS: Human leptin activates PI3K and MAPK pathways in human peripheral blood mononuclear cells: possible role of Sam68. Cell Immunol 2001;212:83-91.
14.
Fernández-Riejos P, Najib S, Santos-Alvarez J, Martín-Romero C, Pérez-Pérez A, González-Yanes C, Sánchez-Margalet V: Role of leptin in the activation of immune cells. Mediators Inflamm 2010;2010:568343.
15.
Youssef DM, Elbehidy RM, Shokry DM, Elbehidy EM: The influence of leptin on Th1/Th2 balance in obese children with asthma. J Bras Pneumol 2013;39:562-568.
16.
Aoki N, Wakisaka G, Nagata I: Effects of thyroxine on T-cell counts and tumour cell rejection in mice. Acta Endocrinol (Copenh) 1976;81:104-109.
17.
Jung T, Schauer U, Heusser C, Neumann C, Rieger C: Detection of intracellular cytokines by flow cytometry. J Immunol Methods 1993;159:197-207.
18.
Zhou L, Chong MM, Littman DR: Plasticity of CD4+ T cell lineage differentiation. Immunity 2009;30:646-655.
19.
Shi Y, Hogue J, Dixit D, Koh J, Olson JA Jr: Functional and genetic studies of isolated cells from parathyroid tumors reveal the complex pathogenesis of parathyroid neoplasia. Proc Natl Acad Sci U S A 2014;11:3092-3097.
20.
Vega L, Montes de Oca P, Saavedra R, Ostrosky-Wegman P: Helper T cell subpopulations from women are more susceptible to the toxic effect of sodium arsenite in vitro. Toxicology 2004;199:121-128.
21.
Schlottfeldt J, Blazina LR, Wannmacher CM, Wajner M: The effect of organic acids on phytohaemagglutinin-activated proliferation of human lymphocytes in vitro. Int J Immunopharmacol 1995;17:175-182.
22.
Zamani A, Vahidinia A, Ghannad MS: The effect of garlic consumption on Th1/Th2 cytokines in phytohemagglutinin (PHA) activated rat spleen lymphocytes. Phytother Res 2009;23:579-581.
23.
Zhang Y, Zhang X, Rabbani ZN, Jackson IL, Vujaskovic Z: Oxidative stress mediates radiation lung injury by inducing apoptosis. Int J Radiat Oncol Biol Phys 2012;83:740-748.
24.
Romero CM, Alvarez JS, Goberna R, Margalet VS: Human leptin enhances activation and proliferation of human circulating T lymphocytes. Cell Immunol 2000;199:15-24.
25.
Lord GM, Matarese G, Howard JK, Bloom SR, Lechler RI: Leptin inhibits the anti-CD3-driven proliferation of peripheral blood T cells but enhances the production of proinflammatory cytokines. J Leukoc Biol 2002;72:330-338.
26.
Yu Y, Liu Y, Shi FD, Zou H, Matarese G, La Cava A: Cutting edge: leptin-induced RORγt expression in CD4+ T cells promotes Th17 responses in systemic lupus erythematosus. J Immunol 2013;190:3054-3058.
27.
Deng J, Liu Y, Yang M, Wang S, Zhang M, Wang X, Ko KH, Hua Z, Sun L, Cao X, Lu L: Leptin exacerbates collagen-induced arthritis via enhancement of Th17 cell response. Arthritis Rheum 2012;64:3564-3573.
28.
Tanaka K, Ichiyama K, Hashimoto M, Yoshida H, Takimoto T, Takaesu G, Torisu T, Hanada T, Yasukawa H, Fukuyama S, Inoue H, Nakanishi Y, Kobayashi T, Yoshimura A: Loss of suppressor of cytokine signaling 1 in helper T cells leads to defective Th17 differentiation by enhancing antagonistic effects of IFN-gamma on STAT3 and Smads. J Immunol 2008;180:3746-3756.
29.
Nakagawa R, Yoshida H, Asakawa M, Tamiya T, Inoue N, Morita R, Inoue H, Nakao A, Yoshimura A: Pyridone 6, a pan-JAK inhibitor, ameliorates allergic skin inflammation of NC/Nga mice via suppression of Th2 and enhancement of Th17. J Immunol 2011;187:4611-4620.
30.
Roskoski R Jr: ERK1/2 MAP kinases: structure, function, and regulation. Pharmacol Res 2012;66:105-143.
31.
Tripathi P, Sahoo N, Ullah U, Kallionpää H, Suneja A, Lahesmaa R, Rao KV: A novel mechanism for ERK-dependent regulation of IL4 transcription during human Th2-cell differentiation. Immunol Cell Biol 2012;90:676-687.
32.
Liu H, Yao S, Dann SM, Qin H, Elson CO, Cong Y: ERK differentially regulates Th17- and Treg-cell development and contributes to the pathogenesis of colitis. Eur J Immunol 2013;43:1716-1726.
33.
Goplen N, Karim Z, Guo L, Zhuang Y, Huang H, Gorska MM, Gelfand E, Pagés G, Pouysségur J, Alam R: ERK1 is important for Th2 differentiation and development of experimental asthma. FASEB J 2012;26:1934-1945.
© 2015 S. Karger AG, Basel
2015
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.